Case studies show oxytocin and magnesium sulfate were included in national protocols for maternal health service provision as well as the EML and standard treatment guidelines in the majority of countries reviewed (where national data was collected and reported), including Ghana, Mali, Malawi, Mongolia, and India. Furthermore, the USAID/MCHIP survey states that most countries—except Rwanda and Ethiopia—reported that they have magnesium sulfate on their EMLs. Ethiopia reports that magnesium sulfate is under review, and it has plans to add it to the list soon. 19 Policy implementation While national policies to support the use of these essential.
